Anti-cancer compound screening identifies Aurora Kinase A inhibition as a means to favor CRISPR/Cas9 gene correction over knock-out. - Wilbie, Danny; Eising, Selma; Amo-Addae, Vicky; Walther, Johanna; Bosman, Esmeralda; Lei, Zhiyong; de Jong, Olivier G; Molenaar, Jan J; Mastrobattista, Enrico (PLoS ONE, 2025)